$MDGL wins FDA approval for NASH/MASH!
$Madrigal Pharmaceuticals (MDGL.US)$ REZDIFFRA as first & only US approved therapy for nonalcoholic steatohepatitis 🎉
ℹ️ REZDIFFRA (Resmetirom)
⇒ THR-β agonist
⇒ once-daily oral therapy #NASH 💊
⇒ Ph3 MAESTRO-NASH trial
⇒ NDA
⇒ PDUFA: 3/14/24
⇒ Approved under accelerated approval 👏
⇒ THR-β agonist
⇒ once-daily oral therapy #NASH 💊
⇒ Ph3 MAESTRO-NASH trial
⇒ NDA
⇒ PDUFA: 3/14/24
⇒ Approved under accelerated approval 👏
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
